Tags

Type your tag names separated by a space and hit enter

Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
Travel Med Infect Dis. 2010 Jul; 8(4):210-2.TM

Abstract

Yellow fever is a mosquito-borne disease, which can cause serious illness. The World Health Organization (WHO) requires travellers to have vaccination against Yellow fever for all international travel going into and from Yellow fever endemic areas in order to prevent the spread of this potentially deadly disease. Only clinics and hospitals authorised by health departments of national governments can administer the disease. Yellow fever vaccination centres are often subject to inspection in many countries, although the requirements for Yellow fever vaccinators (YFV) vary from country to country. In New Zealand, approval of YFV now requires specific postgraduate training in travel medicine or its equivalent, as well as continuing professional development to maintain this status. It is expected that this will assist in improving standards of travel medicine practice in New Zealand.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

O'Brien B
Auckland Regional Public Health Service, Auckland, New Zealand.
Leggat PA
No affiliation info available

MeSH

Health PersonnelHumansImmunization ProgramsNew ZealandTravel MedicineWorkforceYellow FeverYellow Fever Vaccine

Pub Type(s)

Journal Article

Language

eng

PubMed ID

20970723

Citation

O'Brien, Brigid, and Peter A. Leggat. "Linking Yellow Fever Vaccinator Approval and Renewal With Training in Travel Medicine in New Zealand." Travel Medicine and Infectious Disease, vol. 8, no. 4, 2010, pp. 210-2.
O'Brien B, Leggat PA. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand. Travel Med Infect Dis. 2010;8(4):210-2.
O'Brien, B., & Leggat, P. A. (2010). Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand. Travel Medicine and Infectious Disease, 8(4), 210-2. https://doi.org/10.1016/j.tmaid.2010.05.008
O'Brien B, Leggat PA. Linking Yellow Fever Vaccinator Approval and Renewal With Training in Travel Medicine in New Zealand. Travel Med Infect Dis. 2010;8(4):210-2. PubMed PMID: 20970723.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand. AU - O'Brien,Brigid, AU - Leggat,Peter A, Y1 - 2010/06/16/ PY - 2010/05/15/received PY - 2010/05/20/accepted PY - 2010/10/26/entrez PY - 2010/10/26/pubmed PY - 2011/2/23/medline SP - 210 EP - 2 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 8 IS - 4 N2 - Yellow fever is a mosquito-borne disease, which can cause serious illness. The World Health Organization (WHO) requires travellers to have vaccination against Yellow fever for all international travel going into and from Yellow fever endemic areas in order to prevent the spread of this potentially deadly disease. Only clinics and hospitals authorised by health departments of national governments can administer the disease. Yellow fever vaccination centres are often subject to inspection in many countries, although the requirements for Yellow fever vaccinators (YFV) vary from country to country. In New Zealand, approval of YFV now requires specific postgraduate training in travel medicine or its equivalent, as well as continuing professional development to maintain this status. It is expected that this will assist in improving standards of travel medicine practice in New Zealand. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/20970723/Linking_yellow_fever_vaccinator_approval_and_renewal_with_training_in_travel_medicine_in_New_Zealand_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(10)00094-3 DB - PRIME DP - Unbound Medicine ER -